Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balveen Kaur

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Cytokine & Growth Factor Reviews|April 20, 2010
Impact of tumor microenvironment on oncolytic viral therapyJeffrey Wojton, Balveen Kaur
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2025
Cancer interrupted: A story of oncolytic HSV-induced killingUpasana Sahu, Balveen Kaur
Expert Opinion on Biological Therapy|August 7, 2019
Immune therapy, a double-edged sword for oncolytic virusesRyan M McCormack, Balveen Kaur
Expert Review of Neurotherapeutics|April 3, 2013
How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?Walter H Meisen, Balveen Kaur
Journal of Neuro-Oncology|April 22, 2009
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomasRolf F Barth, Balveen Kaur
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Personalizing oncolytic virotherapy?Balveen Kaur, E Antonio Chiocca
Future Microbiology|July 31, 2007
Oncolytic viruses: extreme treatment for an extreme diseaseBalveen Kaur, E Antonio Chiocca
Molecular Therapy Oncolytics|March 30, 2023
Triple combination therapy for pancreatic cancer remodels stroma and improves survivalKarina Vázquez-Arreguín, Balveen Kaur
CNS Oncology|July 24, 2014
How efficient are autophagy inhibitors as treatment for glioblastoma?Jeffrey Wojton, James Elder, Balveen Kaur
Cytokine & Growth Factor Reviews|March 16, 2010
Directing systemic oncolytic viral delivery to tumors via carrier cellsHiroshi Nakashima, Balveen Kaur, E A Chiocca
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Cytokine & Growth Factor Reviews|April 20, 2010
Impact of tumor microenvironment on oncolytic viral therapyJeffrey Wojton, Balveen Kaur
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2025
Cancer interrupted: A story of oncolytic HSV-induced killingUpasana Sahu, Balveen Kaur
Expert Opinion on Biological Therapy|August 7, 2019
Immune therapy, a double-edged sword for oncolytic virusesRyan M McCormack, Balveen Kaur
Expert Review of Neurotherapeutics|April 3, 2013
How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?Walter H Meisen, Balveen Kaur
Journal of Neuro-Oncology|April 22, 2009
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomasRolf F Barth, Balveen Kaur
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Personalizing oncolytic virotherapy?Balveen Kaur, E Antonio Chiocca
Future Microbiology|July 31, 2007
Oncolytic viruses: extreme treatment for an extreme diseaseBalveen Kaur, E Antonio Chiocca
Molecular Therapy Oncolytics|March 30, 2023
Triple combination therapy for pancreatic cancer remodels stroma and improves survivalKarina Vázquez-Arreguín, Balveen Kaur
CNS Oncology|July 24, 2014
How efficient are autophagy inhibitors as treatment for glioblastoma?Jeffrey Wojton, James Elder, Balveen Kaur
Cytokine & Growth Factor Reviews|March 16, 2010
Directing systemic oncolytic viral delivery to tumors via carrier cellsHiroshi Nakashima, Balveen Kaur, E A Chiocca
Pageof 17